Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: A randomized trial

European Journal of Contraception and Reproductive Health Care

Volumn 6, Issue 3, 2001, Pages 134-140

  Carbonell, J L ^a   Velazco, A ^b   Rodriguez, Y ^b   Tanda, R ^b   Sanchcz C ^b   Barambio, S ^c   Valera, L ^b   Chami, S ^d   Valero, F ^e   Aragon S ^a   Mari J ^a  

^a Mediterranea Medica Clinic   (Spain)

^b Hospital Docente Gineco Obstetrico Eusebio Hernandez   (Cuba)

^c Clinica Tutor Medica   (Spain)

^d Clinica Isadora   (Spain)

^e Clinica Delta Medica   (Spain)

Author keywords

Abortion; Cervix; Misoprostol

Indexed keywords

ABORTIVE AGENT; MISOPROSTOL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; NAUSEA; ORAL DRUG ADMINISTRATION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILLS; DIARRHEA; FEMALE; HUMANS; MISOPROSTOL; NAUSEA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0035460071     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.6.3.134.140     Document Type: Article

References (19)

1. Nathason BN. Ambulatory abortion: experience with 26 000 cases. N Engl J Med 1972;286:403-7
2. Hulka JF, Higgins G. Trauma to the external os using dilatation for diagnostic curettage. Am J Obstet Gynecol 1961;113:442-8
3. Molin A. Risk of damage to the cervix by dilatation for first trimester abortion by suction aspiration. Gynecol Obstet Invest 1993;35:152-4
4. Grimes DA, Schultz KF, Gates WJ. Prevention of uterine perforations during curettage abortion. J Am Med Assoc 1984;25:2107-11
5. Schultz KF, Grimes DA, Cates WJ. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182-4
6. Johnson N. Intracervical tents: usage and mode of action. Obstet Gynecol Surv 1989;44:410-20
7. Larang ST, Woo JSK, Tang GWK. Ultrasonic localization of a displacement laminaria tent. Am J Obstet Gynecol 1983;146:410-20
8. El-Refaey H, Calder L, Wheatley DM, Templeton A. Cervical priming with prostaglandins E1 analogues, misoprostol and Gemeprost. Lancet 1994;343:1207-9
9. WHO Task Force on post-ovulatory methods for fertility regulation. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. Br J Obstet Gynaecol 1990;97:260-6
10. Ngai SW, Au Yeung KC, Lao T, Ho PC. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective study. Br J Obstet Gynaecol 1996;103:1120-3
11. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-6
12. Marcisz C, Jonderko G, Gina R, Szkliniarz J. Effect of misoprostol, a synthetic equivalent of prostaglandin E1 on bronchodilation in bronchial spasm. Polski Tygodnik Lekarski 1992;47:733-4
13. Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PYK, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93:275-80
14. Bugalho A, Faundes A, Jamisse L, et al. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception 1996;53:243-6
15. Lawrie A, Penney G, Templeton A. A randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996;103:1117-19
16. Patuszack AL, Schüler L, Speck-Martins CE, et al. Use of misoprostol during pregnancy and Möbius syndrome in infants- N Engl J Med 1998;338:1881-5
17. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998;351:1624-7
18. Goldstein SR. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991;165:497-550
19. Donner A. Approaches to sample size estimation in the design of clinical trials. Stat Med 1984;3:199-214